Literature DB >> 12486487

Mini-review: multiple developmental forms of parkinsonism. The basis for further research as to the pathogenesis of parkinsonism.

P Riederer1, P Foley.   

Abstract

A range of extrapyramidal disturbances have been reported in children following early brain damage. In adults, damage to the basal ganglia can elicit abnormal motor activity in either direction; it would seem reasonable that the same would apply to damage occurring at an earlier developmental stage. The Viennese paediatrician Widhalm described a hypokinetic/parkinsonoid syndrome ("infantile hypokinetic-hypertonic syndrome with Parkinson symptomatic") presented by a significant minority of the children with extrapyramidal movement disturbances, corresponding to the mild rigid-akinetic type of Parkinson's disease. In contrast to classical parkinsonism, but consistent with some forms of post-encephalitic parkinsonism, the syndrome was reversible, although only after L-DOPA therapy. Widhalm's observation that at least one form of childhood parkinsonism can be cured with L-DOPA also suggests that the amino acid plays a more active role than mere replacement therapy in children, perhaps also acting as a neurotrophic agent. It is proposed that environmental factors, including viral and risk factors associated with pregnancy and birth, together with genetically determined lability, may increase the incidence of early hypokinesia/parkinsonism in particular and of Parkinson's disease in later life by disturbing the immature basal ganglia at critical developmental stages. The spectrum disorder of Parkinson's disease thereby occurs as a number of various etiopathologically distinct syndrome subtypes, including early onset developmental forms caused by in utero or early post partum trauma.

Entities:  

Mesh:

Year:  2002        PMID: 12486487     DOI: 10.1007/s007020200095

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  3 in total

Review 1.  The significance of neuronal lateralisation in Parkinson's disease.

Authors:  P Riederer; J Sian-Hülsmann
Journal:  J Neural Transm (Vienna)       Date:  2012-02-26       Impact factor: 3.575

Review 2.  Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2011-02       Impact factor: 3.911

3.  Neuromelanin is an immune stimulator for dendritic cells in vitro.

Authors:  Uwe Oberländer; Katrien Pletinckx; Anja Döhler; Nora Müller; Manfred B Lutz; Thomas Arzberger; Peter Riederer; Manfred Gerlach; Eleni Koutsilieri; Carsten Scheller
Journal:  BMC Neurosci       Date:  2011-11-15       Impact factor: 3.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.